Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same author

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

Blood cancer journal·2026
Same author

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same author

Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti-BCMA CAR T-Cell Therapy: A Case Report.

Case reports in hematology·2026
Same author

Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

Bone marrow transplantation·2026
Same author

PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

Blood·2026

Related Experiment Video

Updated: Dec 25, 2025

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

6.5K

Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells.

Nicolas Espagnolle1,2, Benjamin Hebraud3, Jean-Gérard Descamps1,2

  • 1STROMALab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France.

Stem Cells International
|March 28, 2020
PubMed
Summary

Adipose stromal cells (ASCs) from multiple myeloma (MM) patients show fewer abnormalities than mesenchymal stromal cells (MSCs). However, their potential use in MM bone repair requires further safety and efficacy investigation.

More Related Videos

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
13:26

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Published on: March 31, 2018

10.2K
Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.3K

Related Experiment Videos

Last Updated: Dec 25, 2025

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

6.5K
Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
13:26

Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker

Published on: March 31, 2018

10.2K
Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.3K

Area of Science:

  • Hematology
  • Oncology
  • Regenerative Medicine

Background:

  • Multiple myeloma (MM) is a B cell neoplasm causing bone lesions due to abnormal bone marrow mesenchymal stromal cells (MSCs).
  • Adipose stromal cells (ASCs) are explored as an alternative for cellular therapy in MM bone repair.

Purpose of the Study:

  • To compare adipose stromal cells (ASCs) from multiple myeloma (MM) patients with those from healthy donors (HDs).
  • To evaluate ASCs' potential for repairing MM-induced bone damage.

Main Methods:

  • Transcriptomic, phenotypic, and functional analyses of ASCs and MSCs from MM patients and HDs.
  • Comparison of MM ASCs against autologous MM MSCs and HD counterparts.

Main Results:

  • MM ASCs exhibited fewer abnormalities compared to MM MSCs.
  • Observed changes in MM ASCs and their supportive effect on MM cells raise safety concerns for autologous or allogeneic use.

Conclusions:

  • MM ASCs may not be inherently abnormal like MM MSCs.
  • Further research is needed to assess the safety and efficacy of ASCs for treating MM bone lesions.